Krsnaa Diagnostics balance sheet

As of Mar 2026

Total assets: ₹1,824cr+42.3% on Mar 2025
Shareholders' equity: ₹980cr+11.1% on Mar 2025
Total debt: ₹534cr+162.5% on Mar 2025
Cash and investments: ₹30.2cr+685.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	652	667	645	468
	208	3.0	9.8	25.5
	4.8	2.9	2.4	2.8
	57.4	31.5	0.3	0.3
	35.9	118	32.7	171
	93.3	150	33.0	171
	5.0	3.3	1.6	1.4
	122	40.6	59.1	15.2
	1,085	867	751	684
	26.7	29.5	35.8	25.1
	296	278	176	73.1
	30.2	3.8	2.4	22.7
	330	64.6	51.2	86.1
	31.3	28.3	143	11.8
	688	374	373	194
	24.1	10.5	12.5	7.0
	738	414	421	226
	1,824	1,282	1,172	910
Equity
	16.2	16.1	16.1	15.7
	964	867	794	723
	980	883	810	739
	980	883	810	739
Liabilities
	468	47.2	41.9	24.3
	66.6	20.8	20.6	33.7
	535	68.0	62.4	58.0
	3.2	2.9	1.8	1.2
	30.0	22.6	16.4	12.8
	—	0.0	0.0	0.0
	568	93.4	80.6	72.0
	66.0	156	118	8.2
	63.2	97.1	82.3	62.1
	125	37.1	67.8	24.4
	254	291	268	94.8
	8.6	5.6	4.2	2.2
	3.1	3.8	0.0	—
	9.1	5.4	9.2	2.3
	275	305	281	99.2
	843	399	362	171
	1,824	1,282	1,172	910
Trade payables — MSME split
	0.9	1.0	—	—
	62.4	96.1	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KRSNAA₹497.95

Krsnaa Diagnostics Limited

· Pharma & Health

₹ CrorePeersSURAKSHA HEALTHX NEPHROPLUS 3BBLACKBIOMcap ₹1,615 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	467.8	644.7	667.4	651.6	651.6
+ Capital Work-in-Progress	25.5	9.8	3.0	208.1	208.1
+ Other Intangibles	2.8	2.4	2.9	4.8	4.8
+ Non-current Investments	0.3	0.3	31.5	57.4	57.4
+ Other Non-current Financial Assets	171.1	32.7	118.3	35.9	35.9
Non-current Financial Assets	171.4	33.0	149.8	93.3	93.3
+ Deferred Tax Assets	1.4	1.6	3.3	5.0	5.0
+ Other Non-current Assets	15.2	59.1	40.6	122.5	122.5
Total Non-current Assets	684.1	750.7	867.1	1,085.4	1,085.4
Current Assets
+ Inventories	25.1	35.8	29.5	26.7	26.7
+ Trade Receivables	73.1	176.3	277.7	295.5	295.5
+ Cash & Cash Equivalents	22.7	2.4	3.8	30.2	30.2
+ Other Bank Balances	86.1	51.2	64.6	330.5	330.5
+ Other Current Financial Assets	11.8	143.1	28.3	31.3	31.3
Current Financial Assets	193.7	372.9	374.5	687.5	687.5
+ Other Current Assets	7.0	12.5	10.5	24.1	24.1
Total Current Assets	225.8	421.2	414.5	738.3	738.3
Total Assets	909.9	1,171.9	1,281.6	1,823.7	1,823.7
Equity
+ Equity Share Capital	15.7	16.1	16.1	16.2	16.2
+ Other Equity / Reserves	723.0	793.7	866.6	964.2	964.2
Equity — Owners of Parent	738.7	809.8	882.8	980.4	980.4
Total Equity	738.7	809.8	882.8	980.4	980.4
Liabilities
+ Borrowings — Non-current	24.3	41.9	47.2	468.3	468.3
+ Other Non-current Financial Liab	33.7	20.6	20.8	66.6	66.6
Non-current Financial Liabilities	58.0	62.4	68.0	534.9	534.9
+ Provisions — Non-current	1.2	1.8	2.9	3.2	3.2
+ Deferred Tax Liabilities	12.8	16.4	22.6	30.0	30.0
+ Other Non-current Liabilities	0.0	0.0	0.0	—	—
Non-current Liabilities	72.0	80.6	93.4	568.1	568.1
+ Borrowings — Current	8.2	117.9	156.4	66.0	66.0
+ Trade Payables	62.1	82.3	97.1	63.2	63.2
+ Other Current Financial Liab	24.4	67.8	37.1	125.1	125.1
Current Financial Liabilities	94.8	268.0	290.6	254.3	254.3
+ Provisions — Current	2.2	4.2	5.6	8.6	8.6
+ Current Tax Liabilities	—	0.0	3.8	3.1	3.1
+ Other Current Liabilities	2.3	9.2	5.4	9.1	9.1
Current Liabilities	99.2	281.5	305.4	275.2	275.2
Total Liabilities	171.2	362.1	398.8	843.3	843.3
Total Equity & Liabilities	909.9	1,171.9	1,281.6	1,823.7	1,823.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	1.0	0.9	0.9
+ Dues to Other Creditors — Current	—	—	96.1	62.4	62.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.